New research reveals that people who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt traditional lifestyle plans.
Findings released in a major health publication demonstrates that while overweight people can lose a large proportion of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Users purchasing such treatments should be informed of the potential of quick weight regain when the medication concludes," warns expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to pre-treatment mass within about a year and a half.
Analyzing Treatments
The research, which reviewed 37 of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.
The team note that individuals who shed pounds through diet and exercise generally experience a more gradual weight regain—around 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Nutrition scientists suggest the mechanism of the injections explains the heightened rebound.
These medications imitate a body's own chemical called GLP-1, which moderates hunger.
"Artificially providing the hormone concentrations far above than normal could lead to the system to produce less of its own natural GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this medication leads to hunger is unsuppressed, making binge eating much more probable."
A Chronic Disease?
Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts say that, given the high risk of relapse, the treatment should be considered life-long.
This view is supported by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," comparing it to managing diseases like high blood pressure.
User Accounts
People who have stopped the jabs describe a intense resurgence of appetite.
"It felt as if something flipping and you become starving," recalled an individual.
This difficulty is exacerbated if individuals have not adopted sustainable dietary or behavioural modifications during therapy.
Significant Adoption
Recent estimates indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with interest being substantial.
- Adoption is higher among females than males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
Finally, researchers stress that while the jabs are potent agents for weight loss, they are not a standalone solution and lasting health benefits likely depends on combined lifestyle support.
